Tessera sets CEO Oster and CFO Rokach employment pacts; equity tied to Oct. 20 stockholder vote

BiomX Inc.

CEO Michael Oster gets NIS 55,000 monthly salary (~$18,000), up to 50% cash bonus, 400,000 vested shares, 1,000,000 RSUs, and 1,000,000 options at $1.15.
Oster performance shares: 2027 EBITDA/share above $0.05 yields 200,000 shares plus 100,000 per cent, max 500,000; 2028 threshold $0.10.
CFO David Rokach gets NIS 35,000 monthly salary (~$11,500) and 180,000 fully vested shares; awards need stockholder approval to raise plan shares from 685,000 to 6,000,000.
Special Meeting set for Oct. 20, 2026; Oster pact includes 12-month severance after change in control, full vesting, and option exercise extension to 12 months.
Company says it raised over $6 million via ATM at ~$1.15 average and a financing source added $5 million line of credit; it acquired Zorronet and DFSL.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.